TBC1D3F

Across TCGA pan-cancer cohorts, TBC1D3F RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of TBC1D3F’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where TBC1D3F RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TBC1D3F is over-expressed in tumor.

KIRP, LUSC, and KIRC are the cancer types where TBC1D3F tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TBC1D3F RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	+0.006	.014	4	view →
LUSC	All	II,III,IV	+0.007	.025	2	view →
KIRC	Male	All	+0.002	.023	2	view →
THCA	All	All	+0.003	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

TBC1D3F–KIRP

Open the KIRP breakdown →